Company · CIK 1592052
Centrexion Therapeutics Corp
| CIK | 1592052 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-227902 | 2018-10-19 | 2021-05-05 | 6 |
Filings
7| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2021-05-05 | RWWithdrawn | 333-227902 | 0001193125-21-151155 |
| 2019-12-23 | S-1/AAmendment | 333-227902 | 0001193125-19-322615 |
| 2019-09-18 | S-1/AAmendment | 333-227902 | 0001193125-19-248330 |
| 2018-11-09 | S-1/AAmendment | 333-227902 | 0001193125-18-323752 |
| 2018-11-05 | S-1/AAmendment | 333-227902 | 0001193125-18-317741 |
| 2018-10-19 | S-1Registration filed | 333-227902 | 0001193125-18-303087 |
| 2018-09-10 | DRSDraft made public | 377-02258 | 0000950123-18-009382 |